Drug hypersensitivity reactions in children in clinical practice: A WAO Statement

This publication has 342 references indexed in Scilit:

• Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines
  JAMA Internal Medicine, 2022
• Reintroduction of oxcarbazepine after allergic reaction in two pediatric patients with epilepsy
  Annals of Clinical and Translational Neurology, 2021
• Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA‐B Genotypes and Phenytoin Dosing: 2020 Update
  Clinical Pharmacology & Therapeutics, 2020
• Shared Genetic Risk Factors Across Carbamazepine‐Induced Hypersensitivity Reactions
  Clinical Pharmacology & Therapeutics, 2019
• Association of HLA-A*31:01 Screening With the Incidence of Carbamazepine-Induced Cutaneous Adverse Reactions in a Japanese Population
  JAMA Neurology, 2018
• Levetiracetam: A Possible New Inducer of Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome in 2 Cases
  JAMA Dermatology, 2013
• Poor Benefit/Risk Balance of Intravenous Immunoglobulins in DRESS
  Archives of Dermatology, 2012
• Drug-Induced liver injury with hypersensitivity features has a better outcome: A single-center experience of 39 children and adolescents
  Hepatology, 2011
• Delayed Hypersensitivity Reaction to Vancomycin
  Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1997
• Clinical Classification of Cases of Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome, and Erythema Multiforme
  Archives of Dermatology, 1993